E-LIB Suche - Ergebnisse für: van Pieterson, M

1

N09 Transition Success Score as a valid quantitative measur..:

van Gaalen, M ; van Pieterson, M ; de Ridder, L..
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i2209-i2209 , 2024

Link: https://doi.org/10.1093/..

2

P448 Long term effectiveness of first-line infliximab treat..:

Vuijk, S ; Jongsma, M ; Cozijnsen, M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i579-i580 , 2023

Link: https://doi.org/10.1093/..

3

P100 Serum inflammatory protein profiling to corroborate se..:

Jongsma, M M E ; Costes, L M M ; Tindemans, I...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i197-i198 , 2022

Link: https://doi.org/10.1093/..

4

DOP67 First-line infliximab is cost-effective compared to c..:

Vuijk, S ; Jongsma, M ; Hoeven, B...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i111-i112 , 2022

Link: https://doi.org/10.1093/..

5

P019 Differential effects of first-line IFX and conventiona..:

Jongsma, M ; Costes, L M M ; Tindemans, I...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S137-S138 , 2021

Link: https://doi.org/10.1093/..

6

OP38 Top-down infliximab superior to step-up in children wi..:

Jongsma, M ; Aardoom, M ; Cozijnsen, M...
Journal of Crohn's and Colitis. 14 (2020) Supplement_1 - p. S039-S039 , 2020

Link: https://doi.org/10.1093/..

7

Top-down Infliximab Study in Kids with Crohn's disease (TIS..:

Cozijnsen, M A ; van Pieterson, M ; Samsom, J N..
BMJ Open Gastroenterology. 3 (2016) 1 - p. e000123 , 2016

Link: https://doi.org/10.1136/..

8

P194 - Assessment of self-efficacy during transition in ado..:

Zijlstra, M. ; Breij, L. ; van der Woude, J....
Journal of Crohn's and Colitis. 3 (2009) 1 - p. S87 , 2009

Link: https://doi.org/10.1016/..

9

Top-down Infliximab Study in Kids with Crohn's disease (TIS..:

Cozijnsen, M.A. (Maarten) ; Pieterson, M. (Merel) van ; Samsom, J.N. (Janneke)..
http://repub.eur.nl/pub/100501. , 2016

Link: http://repub.eur.nl/pub/..

10

Randomised clinical trial: First‐line infliximab biosimilar..:

Vuijk, Stephanie A. ; Jongsma, Maria M. E. ; Hoeven, Britt M....
Alimentary Pharmacology & Therapeutics. 59 (2024) 12 - p. 1510-1520 , 2024

Link: https://doi.org/10.1111/..

11

Impact of COVID-19 containment measures on perceived health..:

van Kersen, Warner ; de Rooij, Myrna M. T. ; Portengen, Lützen...
Scientific Reports. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

12

Serum Immune Profiling in Paediatric Crohn's Disease Demons..:

Jongsma, Maria M E ; Costes, Lea M M ; Tindemans, Irma...
Journal of Crohn's and Colitis. 17 (2023) 8 - p. 1262-1277 , 2023

Link: https://doi.org/10.1093/..

13

Potential drivers of spatial distribution of the ghost orch..:

Pieterson, Corrie ; Thomas, Brenda ; Everham III, Edwin M...
Lankesteriana. , 2023

Link: https://doi.org/10.15517..

14

Evaluation of exclusive enteral nutrition and corticosteroi..:

Jongsma, Maria M. E. ; Vuijk, Stephanie A. ; Cozijnsen, Martinus A....
European Journal of Pediatrics. 181 (2022) 8 - p. 3055-3065 , 2022

Link: https://doi.org/10.1007/..

15

Characterization and utility of immobilized metal affinity-..:

Moore, Carson P. ; Pieterson, Kristina ; DeSousa, Jenna M...
Journal of Chromatography B. 1186 (2021) - p. 123023 , 2021

Link: https://doi.org/10.1016/..